Literature DB >> 15141312

Withholding initial vancomycin in febrile neutropenia despite implanted catheters.

Christoph Berger1, Karin Kindli, Felix K Niggli, David Nadal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15141312     DOI： 10.1007/s00431-004-1461-6

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  6 in total

1.  2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.

Authors:  Walter T Hughes; Donald Armstrong; Gerald P Bodey; Eric J Bow; Arthur E Brown; Thierry Calandra; Ronald Feld; Philip A Pizzo; Kenneth V I Rolston; Jerry L Shenep; Lowell S Young
Journal:  Clin Infect Dis       Date:  2002-02-13       Impact factor: 9.079

2.  Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program.

Authors:  A Cometta; T Calandra; H Gaya; S H Zinner; R de Bock; A Del Favero; G Bucaneve; F Crokaert; W V Kern; J Klastersky; I Langenaeken; A Micozzi; A Padmos; M Paesmans; C Viscoli; M P Glauser
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

3.  Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia.

Authors:  M Rubin; J W Hathorn; D Marshall; J Gress; S M Steinberg; P A Pizzo
Journal:  Ann Intern Med       Date:  1988-01       Impact factor: 25.391

4.  Complications of central venous access devices in children with and without cancer.

Authors:  R Tobiansky; K Lui; D M Dalton; P Shaw; H Martin; D Isaacs
Journal:  J Paediatr Child Health       Date:  1997-12       Impact factor: 1.954

5.  Meropenem versus ceftazidime as empirical monotherapy in febrile neutropenia of paediatric patients with cancer.

Authors:  G Fleischhack; C Hartmann; A Simon; B Wulff; W Havers; G Marklein; C Hasan; U Bode
Journal:  J Antimicrob Chemother       Date:  2001-06       Impact factor: 5.790

6.  Imipenem compared with ceftazidime plus vancomycin as initial therapy for fever in neutropenic children with cancer.

Authors:  P Riikonen
Journal:  Pediatr Infect Dis J       Date:  1991-12       Impact factor: 2.129
  6 in total
  1 in total

Review 1.  A systematic review and meta-analysis of anti-pseudomonal penicillins and carbapenems in pediatric febrile neutropenia.

Authors:  Arif Manji; Thomas Lehrnbecher; L Lee Dupuis; Joseph Beyene; Lillian Sung
Journal:  Support Care Cancer       Date:  2011-12-06       Impact factor: 3.603
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.